News Tech and Science

Brazilian researchers discovered antibody fragments produced in horses could be effective to combat Covid

Cloned horse raises hopes for equestrian sports in China
Source: Pixabay

A group of Brazilian researchers discovered that antibody fragments produced in horses could be an effective way to combat Covid-19.

Researchers from the Federal University of Rio de Janeiro immunised horses against SARS-CoV-2 using recombinant trimeric spike (S) glycoprotein to produce hyperimmune serum composed of purified antibody fragments. Following the development of the horse hyperimmune F(ab’)2 concentrate, the researchers conducted challenge tests in hamsters, injecting the substance into the animals.

The findings, published in the journal iScience, demonstrated the treatment’s ability to reduce viral load in pulmonary tissues as well as improve animal clinical conditions as measured by weight gain. During the acute phase of the disease, all intervention schemes protected the animals from weight loss. Non-treated animals lost more weight, whereas pre-treatment resulted in no body weight loss.

“By using the trimeric spike protein of SARS-CoV-2 to immunise horses, a cocktail of purified IgG fragments (F(ab’)2) showing very high neutralising activity was developed. This might be a useful countermeasure against Covid-19, with the added advantages of being an affordable alternative that can be produced in horse serum production facilities available worldwide,” said Professor Leda Castilho, from the Federal University of Rio de Janeiro.

The neutralising activity of the scientists’ sera has also been demonstrated to be high against the P.1 (Gamma) and P.2 Covid variants, according to the researchers.

According to media reports, iSera Biologicals, a Kolhapur-based company, is also using a similar technology for its Covid vaccine.

The drug, made from horse antibodies, is being developed by the company, which claims to cure Covid patients in just 90 hours. The injectable drug is undergoing phase 1 clinical trials against Covid-19 in Maharashtra, and it could be India’s first indigenously developed injectable drug used to treat the viral infection.

The Serum Institute of India (SII) in Pune has provided technology, antigens, and chemicals that stimulate antibody production. SII antigens were injected into horses to induce antibody production, which was then extracted and purified using advanced chromatography technology.


About the author

Brendan Taylor

Brendan Taylor was a TV news producer for 5 and a half years. He is an experienced writer. Brendan covers Breaking News at Insider Paper.

Daily Newsletter